PMS4 - Comparing Costs Per Clinical Remission of Tocilizumab Monotherapy Versus Adalimumab Monotherapy in Patients with Rheumatoid Arthritis: A Brazilian Private Perspective
| Autor: | Buschinelli, C.T., Tsuchiya, C.T., Maximo, M.F.M., Tobaruella, F.S., Gonçalves, T.M. |
|---|---|
| Zdroj: | In Value in Health November 2013 16(7):A716-A716 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect